These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration. Misra M, Webb AT, Reaveley DA, Doherty E, O'Donnell M, Seed M, Brown EA. Adv Perit Dial; 1997 Oct; 13():168-73. PubMed ID: 9360675 [Abstract] [Full Text] [Related]
8. IL-18 is involved in vascular injury in end-stage renal disease patients. Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M. Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894 [Abstract] [Full Text] [Related]
9. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis. Liu BC, Li L, Gao M, Wang YL, Yu JR. Chin Med J (Engl); 2008 Nov 05; 121(21):2157-61. PubMed ID: 19080177 [Abstract] [Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 05; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
14. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation]. Liang M, Wang L, Hou FF, Liu J, Liu ZQ, Tian JW. Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug 05; 23(8):781-4. PubMed ID: 12919896 [Abstract] [Full Text] [Related]
15. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis. Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S. Blood Purif; 2007 Aug 05; 25(5-6):457-65. PubMed ID: 18075247 [Abstract] [Full Text] [Related]